Related Experiment Video
Updated: Apr 28, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
Published on: October 31, 2025
Prevention of post-ERCP pancreatitis
1Lin-Lee Wong, Her-Hsin Tsai, Department of Gastroenterology, Castle Hill Hospital, HEY NHS Trust and Hull York Medical School, Cottingham HU165JQ, United Kingdom.
Post-procedure pancreatitis, a common ERCP complication, can be reduced. Rectal NSAIDs and pancreatic stenting show promise in preventing ERCP-induced pancreatitis in high-risk patients.
Area of Science:
- Gastroenterology
- Endoscopic Procedures
- Medical Complications
Background:
- Post-procedure pancreatitis is a significant complication of Endoscopic Retrograde Cholangiopancreatography (ERCP), occurring in 3-5% of cases.
- This complication carries substantial morbidity and mortality rates.
- Identifying and mitigating risk factors is crucial for patient safety during ERCP.
Purpose of the Study:
- To review the literature on the diagnosis, risk factors, causes, and prevention of post-ERCP pancreatitis.
- To evaluate the evidence for various prophylactic measures, including patient selection, endoscopic techniques, and pharmacological interventions.
- To identify effective strategies for reducing the incidence of ERCP-induced pancreatitis.
Main Methods:
- Comprehensive literature search in PubMed and Medline using keywords: "ERCP", "pancreatitis", and "post-ERCP pancreatitis".
- Review and appraisal of available studies, including meta-analyses, focusing on diagnostic criteria, risk factors, and preventative strategies.
- Analysis of evidence for patient selection, endoscopic techniques, and pharmacological prophylaxis.
Main Results:
- Patient selection based on risk-benefit assessment is key to avoiding unnecessary ERCPs, especially in high-risk groups like young women with Sphincter of Oddi Dysfunction (SOD).
- Emerging evidence suggests pancreatic stenting for SOD patients and rectal nonsteroidal anti-inflammatory drugs (NSAIDs) reduce post-ERCP pancreatitis risk.
- A meta-analysis showed rectal indomethacin significantly lowered pancreatitis rates compared to placebo (OR = 0.49, P = 0.0002), with a Number Needed to Treat of 20.
Conclusions:
- Prophylactic measures are essential for managing the risk of post-ERCP pancreatitis.
- Rectal NSAIDs and pancreatic stenting are promising strategies for high-risk patients.
- Wider adoption of these prophylactic measures in susceptible patient groups is anticipated.
Related Concept Videos
Endoscopic Procedures V: ERCP
Patient...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
